During the past decade, U.T. Medical Center Cancer Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 14 clinical trials were completed, i.e. on average, 466.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "U.T. Medical Center Cancer Institute" #1 sponsor was "SWOG Cancer Research Network" with 12 trials, followed by "NSABP Foundation Inc" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "U.T. Medical Center Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "U.T. Medical Center Cancer Institute" are "Lung Cancer" (6 trials), "Breast Cancer" (4 trials), "Leukemia" (2 trials), "Myelodysplastic Syndromes" (2 trials) and "Myelodysplastic/Myeloproliferative Neoplasms" (2 trials). Many other conditions were trialed in "U.T. Medical Center Cancer Institute" in a lesser frequency.

Most popular intervention types in "U.T. Medical Center Cancer Institute" are "Drug" (24 trials), "Other" (7 trials), "Radiation" (7 trials), "Biological" (6 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "cisplatin" (3 trials), "cetuximab" (2 trials), "conventional surgery" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "U.T. Medical Center Cancer Institute" are 26 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "U.T. Medical Center Cancer Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in U.T. Medical Center Cancer Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in U.T. Medical Center Cancer Institute, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".